Ivan T. Shaw is a neurobiologist by training and an experienced pharmaceutical industry professional. He possesses broad expertise in the full lifecycle of pharmaceutical development, medical affairs, and regulatory affairs. His experience encompasses discovery-stage pre-clinical development through post-marketing lifecycle management, covering adult, pediatric, and orphan indications for small molecules, biologics, and gene therapy. Ivan has served as the CEO for multiple project-focused companies developing oncology, immunology, and neuroscience therapeutic assets to Proof of Concept. He has also held the position of Vice-President, Clinical Development with enGene Inc., Medical Director with Actavis LLC, and Director Clinical Development with Aptalis Pharma Inc. Ivan received his Doctorate in Neurological Sciences/Neurology and Neurosurgery from McGill University, Montréal, Canada.
Access investment thesis, focus areas, bio, and contact details for Ivan T. Shaw, PhD and 22,000+ other VC professionals.